Skip to content

WHWK WHWK Net Income

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.4B+168%
Pfizer logo
PfizerPFE
$2.69B-9.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$727.2M-10.1%
Gilead Sciences logo
Gilead SciencesGILD
$2.02B+53.7%
AbbVie logo
AbbVieABBV
$695M-46.0%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$98.54M-36.5%

Segments

By segment

See full
Reportable-$22.19M-130%

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's net income?
WHWK (WHWK) reported net income of -$22.19M in Q1 2026.
How has WHWK's net income changed year-over-year?
WHWK's net income decreased by 130.4% year-over-year, from $73.02M to -$22.19M.
What is the long-term trend for WHWK's net income?
Over 3 years (2021 to 2025), WHWK's net income has grown at a -42.8% compound annual growth rate (CAGR), from -$110.09M to -$20.6M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.